Finally, we collected clinical samples from 4 non-brain tumor patients and 4 GBM cases for analysis, found that both mRNA (Fig. 1J) and protein levels (Fig. 1K, L) of CSRP2 were significantly higher in GBM than controls. The gene discussed is CSRP2; the disease is brain neoplasm.